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Total esophagogastrectomy in the neoplasms of the esophagus
and esofagogastric junction: when must be indicated?
Esofagogastrectomia total nas neoplasias do esôfago e transição
esofagogástrica: quando deve ser indicada?
NELSON ADAMI ANDREOLLO, TCBC-SP1; JOÃO DE SOUZA COELHO NETO, TGCB-SP2; GUILHERME DELFINO CALOMENI1; LUIZ ROBERTO LOPES,
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A B S T R A C T
Objective: to analyse the indications and results of the total esophagogastrectomy in cancers of the distal esophagus and
esophagogastric junction. Methods: twenty patients with adenocarcinomas were operated with a mean age of 55 ± 9.9 years (31-
70 years), and 14 cases were male (60%). Indications were 18 tumors of the distal esophagus and esophagogastric junction (90%)
and two with invasion of gastric fundus (10%) in patients with previous gastrectomy. Preoperative colonoscopy to exclude colonic
diseases was performed in ten cases. Results: the surgical technique consisted of median laparotomy and left cervicotomy, followed
by transhiatal esophagectomy associated with D2 lymphadenectomy. The reconstructions were performed with eight
esophagocoloduodenoplasty and the others were Roux-en-Y esophagocolojejunoplasty to prevent the alkaline reflux. Three cases
were stage I / II, while 15 cases (85%) were stages III / IV, reflecting late diagnosis of these tumors. The operative mortality was 5
patients (25%): a mediastinitis secondary to necrosis of the transposed colon, abdominal cellulitis secondary to wound infection,
severe pneumonia, an irreversible shock and sepsis associated with colojejunal fistula. Four patients died in the first year after
surgery: 3 (15%) were due to tumor recurrence and 1 (5%) secondary to bronchopneumonia. The 5-year survival was 15%.
Conclusion: the total esophagogastrectomy associated with esophagocoloplasty has high morbidity and mortality, requiring
precise indication, and properly selected patients benefit from the surgery, with the risk-benefit acceptable, contributing to
increased survival and improved quality of life.
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INTRODUCTION
Total esophagogastrectomy and esophagocoloplasty is acomplex surgical procedure, with mortality rates ranging
from 2.5 to 29% and morbidity ranging from 13 to 75% in
1980-2010 published series. The magnitude of the operation
and the severity of the disease which is the surgical indication
are determining factors reported of the high morbidity and
mortality1.
Esophageal reconstructions involving the colon
are described since 1911 by variables causes2. The use of
the colon and esophageal replacement is exceptional, once
the stomach has better elasticity and vascularization. The
total gastrectomy with concomitant esophagectomy is the
main indication for esophagocoloplasty for the reconstruction
of the digestive transit3-6.
The indications of total esophagogastrectomy are
limited to certain conditions, particularly in radical resection
of large tumors of the esophagogastric junction (EGJ)
invading both viscera, esophageal tumors in patients with
previous gastrectomy, severe caustic esophageal lesions with
irreversible loss and stomach and congenital esophageal
atresia7. Therefore, considering the rarity of conditions that
require total esophagogastrectomy, such procedure is the
absolute minority of resection surgeries performed in the
esophagus and / or stomach, and few institutions had
experience with this type of operation8-11.
The aim of this study is to analyse the indications
and results of the total esophagogastrectomy in cancers of
the distal esophagus and esophagogastric junction.
METHODS
From November 1989 to May 2011, 20 patients
underwent total esophagogastrectomy followed by
esophagocoloplasty at the Hospital de Clínicas da Unicamp.
Of these, 14 (60%) were male. The mean age of patients
was 55,7 ± 9,9 years, ranging from 31 to 73 years. Eighteen
patients were white (90%) and two blacks (10%).
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The main symptoms preoperatively reported were
the weight loss in 16 patients (80%), dysphagia in 15 (75%)
and heartburn (seven cases - 35%). Tabagism was observed
in 13 patients (55%), alcohol consumption in 11 (55%)
and the combination of these two habits in 10 (50%).
The most number had low body weight and
therefore low BMI (body mass index). The weight ranged
from 32 kg to 86 kg (mean: 63.66 +/- 13.85) and BMI of
16.3 to 42.4 (mean: 23.8 +/- 5.4).
Among the surgical indications, there were a case
of gastric stump tumor with distal esophageal invasion in
late postoperative Billroth II gastrectomy performed in the
other Service, for treatment of peptic ulcer (Siewert 3), an
early adenocarcinoma in the Barrett’s esophagus  after Roux-
en-Y gastrectomy previously operated in our Service, for
treatment of gastroesophageal reflux disease (GERD), two
advanced adenocarcinomas cases in Barrett’s esophagus
with esophageal and gastric invasion, and 16 cases of
advanced adenocarcinomas of distal esophagus with
invasion of the gastric fundus (Siewert 3). In none of them
was possible the realization of the tumor resection with
adequate surgical margin without removing en block the
two organs involved, the esophagus and the stomach. Three
cases (15%) were in the stages I / II, while 17 cases (85%)
were in the stages III / IV, reflecting late diagnosis of these
tumors (Table 1).
Ten patients underwent preoperative
colonoscopy to exclude colonic diseases that contraindicated
the esophagocoloplasty. The angiography to specific study
of the intestinal vasculature was not performed. Mechanical
preparation of the colon in the immediate preoperative
period consisted of liquid diet and osmotic laxatives. The
surgical technique used was described in the literature10-12.
Were performed 20 total esophagogastrectomies
and in all cases, surgical access consisted xypho-umbilical
midline laparotomy and left neck incision, with an
esophagectomy performed via transhiatal, with D2
lymphadenectomy. Reconstructions were performed in nine
cases by esophacoloduodenoplasty and Roux-en-Y
esophagocolojejunoplasty in 11 cases.
The decision on the colonic segment to be
transposed and route of transposition was always taken in
accordance with the findings of intraoperative evaluation.
Firstly, were performed total mobilization of the ascending
colon, and / or descending through the release of the parieto-
colic peritoneum. Then were identified the colic arteries
employing transillumination and palpation. The feasibility of
the colonic segment chosen was then assessed by selective
clamping of colic pedicle to be connected. The transverse
colon nourished by the left colic pedicle was used in all
patients (100%). The posterior mediastinal route option was
13 patients (65%), while retrosternal route was used in seven
patients (35%). The continuity of colonic transit was restored
by end-to-end manual anastomosis. The
esophagocoloanastomosis was always performed in the neck,
employing end-to-end manual technique in a single plane.
Cervical drainage using a laminar drain was routine.
The integrity of the esophagocoloanastomosis was
routinely assessed by contrast radiography on the eighth
postoperative day or later. Fistula was defined as any
leakage of contrast occurred, regardless of the presence of
clinical manifestations. Outpatient follow-up consisted of
reviews at least fortnightly during the first two postoperative
months and quarterly for the first two years. Any complaint
dysphagia was evaluated with upper digestive endoscopy
being considered stenosis cases that required dilatation.
RESULTS
The average time of surgical hospitalization was
17,4 ± 9,49 days and the patient remained in the intensive
care unit, on average, 5,85 ± 6,69 days. During this period,
12 patients (60%) presented clinical complications. Unila-
teral pleural effusion was noted in seven (35%), requiring
chest drainage in five of them (25%). Bronchopneumonia
was diagnosed in 3 patients (15%). The mean follow-up
was 31,1 ± 62,9 months with a maximum of 255 months.
Additional procedures were necessary in some
patients (Table 2). The jejunostomy was performed in 17
patients (85%). Splenectomy occurred in 17 patients (85%),
cholecystectomy in 13 (65%), chest drain in 11 (55%), caudal
pancreatectomy in two (10%) and hepatic nodulectomy in
two (10%).
Table 1 - Age, gender, surgical indications and staging.
Age (years) 55.75 ± 9.93
Gender
Male 14 (70%)
 Female 6 (30%)
Surgical Indications
Adenocarcinoma of esophagogastric  junction 20 (100%)
 Squamous cell carcinoma 0 (0%)
Staging
I/II 3 (15%)
 III/IV 17 (85%)
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Surgical complications were diagnosed in six ca-
ses (30%) during the immediate postoperative
hospitalization. There was only one necrosis of the
transposed colon (5%), which was treated with resection
of necrotic bowel, followed by cervical esophagostomy and
jejunostomy. One patient presented acute intestinal
obstruction by adhesions (5%), and required surgical
approach on the thirteenth postoperative day. Finally, in
four cases were diagnosed cervical anastomotic leaks
(20%), three of them treated properly only with clinical
measures (15%). Were recorded two fistulas of the abdo-
minal colonic anastomosis, treated medically and with to-
tal parenteral nutrition with favorable outcome.
Perioperative mortality observed was five cases
(25%), due to one mediastinitis secondary to necrosis of
the transposed colon; one abdominal cellulitis secondary
to wound infection that evolved to severe sepsis; one patient
with irreversible shock at the end of the operation and died
in the first postoperative day; one severe pneumonia with
sepsis and cervical fistula; and one sepsis associated with
abdominal fistula of the colojejunoanastomosis. It was not
registered intra-operative mortality.
Neoadjuvant chemoradiotherapy was not
employed because it is not the Service Protocol. However,
six patients received adjuvant chemoradiotherapy.
Considering the long-term ambulatory follow-up,
they can eat solids, soft and well cooked foods, and the
most common complaint in cases submitted to
esophagocoloduodenoplasty was the alkaline reflux. Due
to this complaint greatly exacerbated, two patients
underwent reoperation for conversion to Roux-en-Y
esophagocolojejunoplasty. Thus, this latter technique was
adopted as a routine in the Service after 2004. Moreover,
stenosis of cervical anastomosis was diagnosed in three
patients (15%), and two of them appear in the cases that
presented previous anastomosis fistula. In all cases,
endoscopic dilations were sufficient to treat this
complication. Left vocal cord paralysis secondary to recurrent
laryngeal nerve injury was observed in one patient (5%).
There was no case of chylothorax or redundancy of the
transposed colon.
Regarding late mortality, were recorded eight
deaths (40%), half of them before one year in the
postoperative period, including two due to tumor recurrence;
one due to a severe lack of appetite, malnutrition and
unconfirmed tumor recurrence; and the other due to
bronchopneumonia, pulmonary embolism and sepsis. All
the deaths during the late follow-up after one year were
due to tumor recurrence or metastasis.
The histopathologies studies revealed in three
patients (17.6%) involvement of radial margins. There was
not, however, involvement of proximal and distal margins
in any case. Tumor recurrence was recorded in nine patients
(45%), and occurred between two months to eight years
and nine months after the operation, with an average of
24.2 months. Interestingly, in the group of patients with I
stages, no recurrences or deaths were observed, and such
complications were restricted to cases of advanced tumors.
The five year survival was 15%.
DISCUSSION
Few studies analyzing total esofagogastrectomies
exist in contemporary literature. In fact, only a few
specialized services perform this procedure. German authors
Table 2 - Surgical procedures performed.
Surgical Procedures Number of patients
Resection
 Total esophagogastrectomy 20
Reconstruction 
Esophagocoloduodenoplasty 9 (45%)
Roux-en-Y Esophagocolojejunoplasty 11 (55%)
Route of Reconstruction
Posterior mediastinal 13 (65%)
Retroesternal 7 (35%)
Colon Transposition
Transverse colon (left colic artery) 20 (100%)
Ascendent colon (middle colic artery) 0 (0%)
OtherProcedures
Jejunostomy 17 (85%)
 Splenectomy 17 (85%)
 Cholecystectomy 13 (65%)
 Chest drainage 11 (55%)
 Caudal pancreatectomy 2 (10%)
 Hepatic nodulectomy 2 (10%)
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state that only 13% of medical institutions in the country
have any experience with this surgery8,9. In published series
of esophageal resection, total esofagogastrectomy represent
no more than 10% of the procedures5,12,13.
The mainly indication for such a complex
operation are restricted and tumors of esophagogastric
junction, and the minority that affect large portions of the
esophagus and stomach, extrapolating Siewert classification
(14). The advanced nature of these tumors at the time of
diagnosis, justifies the prognosis of patients10,14-17. This
characteristic is clear in this series of cases, of which 80%
belonging to stages III and IV.
The stomach is considered the main viscera for
the reconstruction of the upper digestive tract, and of course
the concomitant gastrectomy prevents such procedure,
requiring the esophagocoloplasty, and  in these cases it is
predominant the esophageal squamous cell carcinoma.
Among benign diseases, severe cases of caustic stenosis
with concomitant esophageal and gastric lesions are the
main indications. And such patients usually attempted pri-
or endoscopic treatment employing dilations, but did not
obtain satisfactory results2-4,18-22.
The advantages of using the colon as esophageal
substitute include its good vascularization, its long extension
and its relative resistance to acid reflux. The disadvantages
involve longer surgical time and the need for two extra
anastomoses5,12,23,24. In fact, many current studies show that
the use of the colon esophageal replacement determines
higher morbidity, but the mortality is the same3,21.
There is no consensus as to the best colonic
segment for transposition. There are authors that
recommend the right colon and others who prefer the left.
Similarly, there is controversy on the issue of better
transposition pathway. Proponents of retrosternal route claim
that infectious complications would be less disastrous6, while
supporters of the posterior mediastinal route emphasize the
shortest distance and better functional results12,20. This study
shows the functional quality of transposition through poste-
rior mediastinal, dependent on the left colic pedicle,
because it occurred to just one case of transposed colon
necrosis case and no registered redundancy.
The total esophagogastrectomy associated with
esophacoloplasty makes more complex the operation,
justifying the high levels of morbidity and mortality
associated. Postoperative complications vary from 41 to
67% in the contemporary literature, mainly the pneumo-
nia, pleural effusion and fistulas In fact, cervical anastomosis
fistulas are from 5.8 to 46% of the cases5,8,12,17,19,21,24. Despite
the frequency of this complication, treatment with oral
fasting or soft diet associated with cervical drainage is
resolving most of the time. Fortunately, transposed colon
necrosis is rare, ranging from 0 to 9.4% and its outcome is
often the patient’s death. Finally, stenosis of the cervical
anastomosis, late complication, occurs in 6-46% of cases
with an endoscopic dilation treatment usually efficient.
Regarding mortality associated with the procedure are values
between 0 and 17%, with survival rates at five years
between 10 and 48% These values reflect the severity of
the disease 5,8,12,19,21,24,25.
Tumor recurrence affects the prognosis and
quality of life of patients after total esofagogastrectomy.
Factors associated with higher cancer recurrence risks
include tumor differentiation, advanced stage, lymph node
invasion and involvement of surgical margins. Treatment
of local recurrence is extremely complex, with greater
difficulty in the posterior mediastinal transposition26-28. The
recurrence recorded in the patients described here was
restricted to stages III and IV, attesting to the greater
relevance of tumor aggressiveness.
The study in our Service27, including 103 patients
with adenocarcinoma of the esophagogastric junction,
comparing 78 submitted to surgical treatment with 25
submitted to the operation followed by chemoradiation,
using the protocol of Macdonald et al., showed no increase
in survival at five years of follow-up.
Publications reporting this procedure in the
literature are rare. Moreno-Gonzalez et al16 in Spain,
reported three cases of total esophagogastrectomy in
advanced tumors of esophagogastric junction. Abularach
C et al.18 in Chile, reported the same surgery in five cases
of tumors of esophagogastric junction, patients with a mean
age of 50 years, mean hospital stay of 20 days, without
mortality. Munoz-Bongrand et al12. describe the surgical
technic of the total esophagogastrectomy emphasizing the
need for a jejunostomy for postoperative parenteral nutrition,
and extensive drainage of the peritoneal cavity due to the
risk of postoperative fistula. Yasuda et al30 emphasize that
the reconstruction of the digestive tract should preferably
be isoperistaltic and using posterior mediastinum. This
procedure has the advantage that a shorter path, however,
has the disadvantage of occurrence of colon necrosis, which
is fatal. Conclude that it is a procedure with high risk of
complications and not negligible mortality.
Finally, there are few studies evaluating quality
of life of patients undergoing total esophagogastrectomy.
The most of them lose weight, but eventually stabilize at a
new level that will not compromise your health, usually
around 90% of preoperative weight6,11,29. Yasuda et al30.
reported that the functional result of esophagocoloplasty
looks worse than the reconstruction with gastric tube, but
acceptable regarding the need of the patient. Other
studies6,9,12,31 have shown that after three months of surgery,
49 to 78% of patients report good food intake, and this
figure rises to 82 to 89% with one year of the procedure.
The main symptoms reported in the late outpatient treatment
include dysphagia (10 to 40%), reflux (8 to 24%), diarrhea
(10 to 39%) and dumping syndrome (24%).
Concluding, the total esophagogastrectomy
associated with esophagocoloplasty are a high morbidity
and mortality procedure, therefore requiring precise
indication, with the risk-benefit acceptable. The results of
the procedures performed in our Service are similar to those
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of the best international centers, encouraging us to conti-
nue to hold such a large operation, for the benefit of the
patient, both in survival and in improving their quality of
life.
R E S U M O
Objetivo: avaliar as indicações e resultados da esofagogastrectomia total seguida de esofagocoloplastia, nas neoplasias do esôfago
distal e da transição esofagogástrica. Métodos: foram avaliados os dados epidemiológicos, o quadro clínico, a indicação cirúrgica,
o tipo de reconstrução, as complicações clínicas e cirúrgicas e a mortalidade.  Resultados: Nas reconstruções foram realizadas oito
esofagocoloduodenoplastias e as demais foram esofagocolojejunoplastias em Y de Roux, visando prevenir o refluxo alcalino. Três
casos eram estádios I/II, enquanto 15 (85%) casos eram estádios III/IV, refletindo o diagnóstico tardio destes tumores. A mortalidade
operatória foi cinco pacientes (25%): uma mediastinite secundária à necrose do cólon transposto, uma celulite abdominal secundária
à infecção de ferida operatória, uma broncopneumonia grave, um choque irreversível e uma sepse associada à fístula colojejunal.
Quatro doentes morreram no primeiro ano de pós-operatório, sendo que três (15%) deveram-se à recidiva tumoral e um (5%)
secundário à broncopneumonia. A sobrevida de cinco anos foi 15%. Conclusão: a esofagogastrectomia total associada à
esofagocoloplastia apresenta elevada morbimortalidade, necessitando indicação precisa. Os pacientes corretamente selecionados
beneficiam-se da operação, sendo o risco-benefício aceitável, contribuindo para o aumento da sobrevida e melhora da qualidade de
vida.
Descritores: Adenocarcinoma. Esôfago. Procedimentos Cirúrgicos Operatórios. Esofagectomia.
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